Initial validation of a virtual blood draw exposure paradigm for fear of blood and needles.
Z Trost, A Jones, A Guck...
https://pubmed.ncbi.nlm.nih.gov/28780134/Actively Recruiting
Led by Simon Fraser University · Updated on 2025-05-15
20
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are studying how the bodys cardiovascular autonomic system responds to emotional triggers, specifically blood-injection-injury needle phobia, during an upright posture challenge. This study compares individuals with and without needle phobia to better understand why some people have low blood pressure reactions that can lead to fainting. Such reactions are common in medical settings and can cause avoidance of important health care, which impacts public health and healthcare systems. Participants will undergo a tilt test on two separate days in a randomized order. On one day, they will view images and videos related to blood-injection-injury phobia, and on the other day, they will see neutral content. Each exposure lasts about 498 seconds and begins two minutes before the upright tilt test. Cardiovascular responses will be closely monitored throughout the tests. During the study, volunteers will be assessed for cardiovascular control and tolerance to standing upright, measured by the time until near fainting occurs. Researchers will record heart and blood pressure changes while participants watch the videos and images. The main outcome is orthostatic tolerance, observed over a period of up to 50 minutes. The study aims to provide detailed insights into fainting susceptibility related to needle phobia and will run until December 2026.
CONDITIONS
Impact of Blood Phobia on Fainting Susceptibility
V
Victoria E Claydon, PhD
V
Vera E Lucci, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Simon Fraser University
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 2 separate days
Participants undergo two separate test days where they watch either blood-injection-injury phobia stimuli or neutral stimuli during an upright tilt test to assess cardiovascular responses and orthostatic tolerance.
2 visits (in-person)
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Z Trost, A Jones, A Guck...
https://pubmed.ncbi.nlm.nih.gov/28780134/Victoria E Claydon, Christoph Schroeder, Lucy J Norcliffe...
https://pubmed.ncbi.nlm.nih.gov/16321141/Frederick S Stinson, Deborah A Dawson, S Patricia Chou...
https://pubmed.ncbi.nlm.nih.gov/17335637/Victoria E Claydon, Roger Hainsworth
https://pubmed.ncbi.nlm.nih.gov/14564654/K M el-Bedawi, R Hainsworth
https://pubmed.ncbi.nlm.nih.gov/8054836/Victoria E Claydon, Roger Hainsworth
https://pubmed.ncbi.nlm.nih.gov/14981050/V L Cooper, R Hainsworth
https://pubmed.ncbi.nlm.nih.gov/11571497/C M Brown, R Hainsworth
https://pubmed.ncbi.nlm.nih.gov/10823336/Christoph Schroeder, Victoria E Bush, Lucy J Norcliffe...
https://pubmed.ncbi.nlm.nih.gov/12451007/Christopher R France, Janis L France, Lina K Himawan...
https://pubmed.ncbi.nlm.nih.gov/22670781/Simon Fraser University
Lead Sponsor